A Win For Tonix Pharmaceuticals Holding Corp.
Thu, Mar 03, 2022 at 05:30 PM
Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ) rocketted at $0.25, a gain of 33.1%. On Wed, Mar 02, 2022, TNXP:NASDAQ touched a New 2-Week Intraday High of $0.21. The stock appeared on our News Catalysts scanner on Thu, Mar 03, 2022 at 07:23 AM in the 'BIOTECH' category. From Wed, Feb 16, 2022, the stock recorded 33.33% Up Days and 30.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ)
Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company dedicated to the development of pharmaceutical products to address public health challenges. Its drug development program is focused on delivering treatment for PTSD.
Top 10 Gainers:
- Indonesia Energy Corporation Limited (INDO:NYSEMKT), 39.31%
- DBV Technologies S.A. (DBVT:NASDAQ), 34.62%
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 33.07%
- Rimini Street, Inc. (RMNI:NASDAQ), 26.27%
- RiceBran Technologies (RIBT:NASDAQ), 23.56%
- Hour Loop Inc. (HOUR:NASDAQ), 21.85%
- EzFill Holdings Inc. (EZFL:NASDAQ), 20.19%
- Eos Energy Enterprises Inc. (EOSE:NASDAQ), 19.08%
- Document Security Systems, Inc. (DSS:NYSEMKT), 18.94%
- Ferroglobe PLC (GSM:NASDAQ), 18.87%